ArticleChina CDC weekly2026
A Review and Future Directions for Global Public Health Security Assessment Tools.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the context of globalization, national capacities for responding to public health emergencies are evaluated using various global assessment tools, most notably the externally derived Global Health Security Index (GHSI), the peer-reviewed Joint External Evaluation (JEE), and the self-reported States Parties Self-Assessment Annual Report (SPAR). These instruments are designed to strengthen emergency response systems worldwide. However, the dynamic transmission characteristics of the COVID-19 pandemic exposed significant discrepancies, as assessment scores from these tools did not consistently align with countries' actual pandemic response performance. This review examines the performance of these assessment tools throughout the pandemic and identifies three fundamental issues that undermined the effectiveness of GHSI, JEE, and SPAR evaluations. Although indicators across eight technical areas were revised following the pandemic, substantial modifications remain necessary to address the identified limitations. To enhance the utility of these assessment frameworks, systematic revisions are required in multiple domains: restructuring the indicator system architecture, diversifying data sources while expanding indicator dimensions, strengthening data verification protocols, refining weight allocation methodologies, incorporating real-time data streams, and ultimately establishing a dynamic monitoring and assessment system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.